Remove FDA Remove Governance Remove Health Care Access Remove Malpractice
article thumbnail

Health Provider News

Hall Render

Health Policy Commission still missing key document in Steward sale to Optum Local obesity drug developer lands deal worth up to $600M with Novo Nordisk Mass. Health Policy Commission still missing key document in Steward sale to Optum Local obesity drug developer lands deal worth up to $600M with Novo Nordisk Mass.

article thumbnail

Health Provider News

Hall Render

The CDC has stopped printing them Telehealth Visits Decline 46%, But Telebehavioral Healthcare Still High URAC to offer health equity accreditation Walgreens CIO is latest to leave in company’s C-suite shakeup AI is creating a complex landscape for healthcare executives ALABAMA Alabama hospital to remain on Cerner after sale Alabama gets $3.6M

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Health Provider News

Hall Render

The CDC has stopped printing them Telehealth Visits Decline 46%, But Telebehavioral Healthcare Still High URAC to offer health equity accreditation Walgreens CIO is latest to leave in company’s C-suite shakeup AI is creating a complex landscape for healthcare executives ALABAMA Alabama hospital to remain on Cerner after sale Alabama gets $3.6M

article thumbnail

Health Provider News

Hall Render

Washington Pediatric Hospital names new CEO Addressing health disparities in Maryland Montgomery County Tops Maryland Health Rankings Maryland named 2023’s 7th best state for children’s health care, WalletHub study Military hospital chided for shift in Catholic pastoral care Baltimore digital health startup Scene Health raises $17.7

article thumbnail

Health Provider News

Hall Render

Mental health hospital slated for Wichita could solve some problems but faces staffing questions Missouri and Kansas limit payouts in medical malpractice lawsuits. acres from Our Lady of Lourdes for new health sciences center New gene therapies are a near-cure for Louisiana’s sickle cell patients. But who really benefits?